AnteoTech Limited (ASX:ADO)

Market Cap	18.94M
Revenue (ttm)	-545.39K
Net Income (ttm)	-8.72M
Shares Out	2.71B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,169,514
Average Volume	7,330,223
Open	0.0080
Previous Close	0.0080
Day's Range	0.0070 - 0.0080
52-Week Range	0.0070 - 0.0370
Beta	1.03
RSI	28.13
Earnings Date	Apr 30, 2025

About AnteoTech

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, North America, and Latin America. Its products include AnteoBind, s an activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit , a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-ba...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Merrill Gray
• Employees: 99
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ADO

Financial Performance

In 2024, AnteoTech's revenue was 460,397, an increase of 25.89% compared to the previous year's 365,724. Losses were -8.88 million, -29.82% less than in 2023.